Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI
Refereed Congress / Symposium Publications in Proceedings

DeepResponse: Large Scale Prediction of Cancer Cell Line Drug Response with Deep Learning Based Pharmacogenomic Modelling

16th International Symposium on Health Informatics and Bioinformatics (HIBIT 2023), Ankara, Turkey, 4 - 06 October 2023

Anti-Cancer and Anti-Stemness Action of Nonsteroidal Anti-Inflammatory Agents: A Special Focus on Hepatocellular Carcinoma

3rd International Multidisciplinary Cancer Research Congress, İstanbul, Turkey, 7 - 10 September 2023

Experimental validation of drug responses predicted by deep learning-based bioactivity models in hepatocellular carcinoma cell lines

15th International Symposium on Health Informatics and Bioinformatics (HIBIT 2022), Mersin, Turkey, 20 - 22 October 2022

A Multi-Omics and Machine Learning-Based Predictor of Drug Sensitivity in Cancer

15th International Symposium on Health Informatics and Bioinformatics (HIBIT 2022), Mersin, Turkey, 20 - 22 October 2022

A NEW THIADIAZINE DERIVATIVE INDUCES OXIDATIVE STRESS DEPENDENT CELL DEATH IN HEPATOCELLULAR CARCINOMA STEM CELLS

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, United States Of America, 8 - 12 November 2019, vol.70 identifier

A new thiadiazine derivative induces oxidative stress dependent JNK pathway activation and cell death in hepatocellular carcinoma

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Georgia, United States Of America, 29 March - 03 April 2019, vol.79 identifier

In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Georgia, United States Of America, 29 March - 03 April 2019, vol.79 identifier

Identification of interleukin 8 as a cancer stem cell enrichment stimulating factor in HCC

11th International Symposium on Health Informatics and Bioinformatics (HIBIT 2018), Antalya, Turkey, 25 - 27 October 2018

Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib

American Association for Cancer Research Annual Meeting 2018, Chicago, United States Of America, 12 - 18 April 2018, vol.78, pp.3937 Sustainable Development

Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells

AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, United States Of America, 26 - 30 October 2017 identifier

Potency of Interleukin 8 Blockade in Prevention of Liver Cancer Stem Cell Enrichment

5th International BAU Drug Design Congress, İstanbul, Turkey, 19 - 21 October 2017

Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment

24th Biennial Congress of the European Association for Cancer Research, Manchester, England, 9 - 12 July 2016

Recent Advances in Cancer Stem Cell Research

COST Action CM1106 4th Workshop, Venedik, Italy, 10 - 11 March 2016

Bioactivities of small molecule kinase inhibitors in liver cancer stem cells

COST Action CM1106 3rd Working Group Meeting, ATİNA, Greece, 26 - 27 March 2015

Identification of Novel Small Molecule Kinase Inhibitors Against Liver Cancer Stem Cells

EACR Sponsored 2nd Anticancer Agents Congress and 5th Multidisciplinary Cancer Research Congress, Muğla, Turkey, 23 - 25 April 2014
Metrics

Publication

54

Citation (WoS)

525

H-Index (WoS)

14

Citation (Scopus)

560

H-Index (Scopus)

13

H-Index (Scholar)

1

Project

5

Thesis Advisory

3

Open Access

9
UN Sustainable Development Goals